Pharmaterials Limited

Pharmaterials Ltd is a science driven contract research organization specializing in the optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trials materials. Pharmaterials have a wealth of experience in the development of low solubility drug substances and have taken a great many such formulations to the clinic. We provide a complete formulation service for inhaled drug delivery using dry powder inhaler (DPI) and pressurized metered dose inhaler (pMDI) systems. Using high-throughput screening technologies in both physical form generation and formulation design, we assist biotechnology and pharmaceutical companies to rapidly and successfuly progress their problematic lead compounds into the clinical phases of development. With partnerships that span the globe, Pharmaterials works with a range of organisations, including start-up, mid-size and multinational companies. We can assist or manage projects as needed, from bespoke salt selection and polymorphism screening services through to full formulation screening and development programs.